Please assess the completion status of the following clinical trial:

Trial Title: In Vitro Myometrial Contractions in Laboring and Non-laboring Women

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Gestational age 37-41 weeks~* Patients requiring primary or first repeat Cesarean section~* Cesarean section under spinal anesthesia~Exclusion Criteria:~* Patients who require general anesthesia~* Patient who had previous myometrial surgery or more than one previous Cesarean section~* Patients with placental anomalies~* Patients with multiple pregnancy (twins, etc.)

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treatment (Type: EXPERIMENTAL): All samples will undergo dose response treatment (increasing concentrations) of one of the four uterotonic drugs: oxytocin, ergonovine, prostaglandin F2alpha, or misoprostol.

Based on this trial design, predict the completion outcome and termination type (if applicable).